» Articles » PMID: 22056143

Methylation of Cancer-stem-cell-associated Wnt Target Genes Predicts Poor Prognosis in Colorectal Cancer Patients

Abstract

Gene signatures derived from cancer stem cells (CSCs) predict tumor recurrence for many forms of cancer. Here, we derived a gene signature for colorectal CSCs defined by high Wnt signaling activity, which in agreement with previous observations predicts poor prognosis. Surprisingly, however, we found that elevated expression of Wnt targets was actually associated with good prognosis, while patient tumors with low expression of Wnt target genes segregated with immature stem cell signatures. We discovered that several Wnt target genes, including ASCL2 and LGR5, become silenced by CpG island methylation during progression of tumorigenesis, and that their re-expression was associated with reduced tumor growth. Taken together, our data show that promoter methylation of Wnt target genes is a strong predictor for recurrence of colorectal cancer, and suggest that CSC gene signatures, rather than reflecting CSC numbers, may reflect differentiation status of the malignant tissue.

Citing Articles

To investigate the tumor promotion role of PLOD3 in colorectal cancer and its potential as a prognostic biomarker and therapeutic target.

Dong W, Li S, Tang W, Sun Q, Zhu P, Wang M Sci Rep. 2025; 15(1):5371.

PMID: 39948137 PMC: 11825652. DOI: 10.1038/s41598-025-89521-z.


Integrated multi-omics analysis reveals clinical significance of hepatocyte nuclear factor-1β in tumor immune microenvironment, immunotherapy and prognostic prediction for colon adenocarcinoma.

Gao F, Gong W, He H, Zhang Z, Yang H, Shao F Cancer Immunol Immunother. 2024; 74(1):38.

PMID: 39738645 PMC: 11685357. DOI: 10.1007/s00262-024-03870-8.


Gradient boosting reveals spatially diverse cholesterol gene signatures in colon cancer.

Yang X, Chatterjee D, Couetil J, Liu Z, Ardon V, Chen C Front Genet. 2024; 15:1410353.

PMID: 39678375 PMC: 11638177. DOI: 10.3389/fgene.2024.1410353.


Novel PROTAC probes targeting KDM3 degradation to eliminate colorectal cancer stem cells through inhibition of Wnt/β-catenin signaling.

Zaman S, Pagare P, Ma H, Hoyle R, Zhang Y, Li J RSC Med Chem. 2024; .

PMID: 39281802 PMC: 11393732. DOI: 10.1039/d4md00122b.


Exploring LGR5 as a prognostic marker of extrahepatic cholangiocarcinoma: insights from expression analysis and clinical correlations.

Tamada H, Uehara T, Yoshizawa T, Iwaya M, Asaka S, Nakajima T Diagn Pathol. 2024; 19(1):116.

PMID: 39198902 PMC: 11350935. DOI: 10.1186/s13000-024-01537-7.